Visalytics
Visalytics
approved EB-2 (NIW)

PhD Candidate

Neuroscience · Iran · 2023-06-02

Processing Time
8 days
Decision Date
2023-06-02
Location
North Carolina
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to conduct groundbreaking research into the rewarding and analgesic properties of opioid drugs and the role of various brain cell types in addiction. Her work also explores the potential of cannabinoid drugs to prevent neurological conditions such as epilepsy. The goal is to develop safer analgesics and innovative adjuvant therapies to directly address the national opioid crisis.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the opioid crisis and neurological conditions like epilepsy, which are critical national health priorities.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of high-impact publications, NIH funding, and expert endorsements proves she is well-positioned.

3 Balance of Interests Met

The urgent need for safer pain management and addiction therapies makes it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's authorship of 6 peer-reviewed articles with 30 citations, including two papers ranked in the top 1% and 10% of their field. She also demonstrated her expertise through 3 peer reviews and receipt of prestigious NIH funding. The case was supported by two expert recommendation letters confirming her status as a major contributor to neuroscience.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Grants
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
North Carolina 116 days 2022-10-08
The petitioner proposes to continue her research on identifying biomarkers and cognitive processes associated with chronic pain to develop improved monitoring and treatment methods. Her work focuses on the mechanisms of chronic pain and its effects on the body's reward center to create safer alternatives to opioids.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) rfe approved
Virginia 180 days 2023-03-31
The petitioner proposes to focus on pre-clinical toxicity studies of novel small molecules and the safety monitoring of pharmaceutical therapies for conditions including alcohol and opioid dependence, schizophrenia, bipolar disorder, cancers, and neurodegenerative disorders. This work aims to develop viable new drug treatments and reduce preclinical trial costs.
View Case

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
California 174 days 2022-09-29
The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.
View Case

Research Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Virginia 330 days 2025-05-13
The petitioner proposes to develop targeted gene therapies for chronic pain management by investigating cellular and molecular mechanisms in the brain. The work focuses on studying specific neural circuits and epigenetic pathways, such as circular RNAs and allele-specific enhancers, to address the root causes of pain perception and provide safer alternatives to opioids.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-06-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist